|
1AL2
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I
Deposited 1997-06-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
|
SPH SPHINGOSINE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AL2
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I
Deposited 1997-06-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AL2
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I
Deposited 1997-06-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
|
SPH SPHINGOSINE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AL2
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I
Deposited 1997-06-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
|
SPH SPHINGOSINE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AL2
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I
Deposited 1997-06-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AL2
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I
Deposited 1997-06-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 150
PDB declaration: 150-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
Mutation:CHAIN 1, V160I
|
SPH SPHINGOSINE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR6
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
|
SPH SPHINGOSINE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR6
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR6
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
|
SPH SPHINGOSINE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR6
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
|
SPH SPHINGOSINE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR6
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR6
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 150
PDB declaration: 150-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
Mutation:CHAIN 1, P95S, V160I
|
SPH SPHINGOSINE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR7
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
|
SPH SPHINGOSINE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR7
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR7
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
|
SPH SPHINGOSINE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR7
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
|
SPH SPHINGOSINE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR7
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR7
P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 150
PDB declaration: 150-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
Mutation:CHAIN 1, P95S, CHAIN 2, H142Y
|
SPH SPHINGOSINE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR8
P1/MAHONEY POLIOVIRUS, MUTANT P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
|
SPH SPHINGOSINE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR8
P1/MAHONEY POLIOVIRUS, MUTANT P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR8
P1/MAHONEY POLIOVIRUS, MUTANT P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
|
SPH SPHINGOSINE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR8
P1/MAHONEY POLIOVIRUS, MUTANT P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
|
SPH SPHINGOSINE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR8
P1/MAHONEY POLIOVIRUS, MUTANT P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR8
P1/MAHONEY POLIOVIRUS, MUTANT P1095S
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 150
PDB declaration: 150-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
Mutation:CHAIN 1, P95S
|
SPH SPHINGOSINE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR9
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
|
SPH SPHINGOSINE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR9
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR9
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
|
SPH SPHINGOSINE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR9
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
|
SPH SPHINGOSINE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR9
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1AR9
P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y
Deposited 1997-08-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 150
PDB declaration: 150-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
Mutation:CHAIN 2, H142Y
|
SPH SPHINGOSINE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1ASJ
P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE
Deposited 1997-08-11
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Not recorded
|
SPH SPHINGOSINE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1ASJ
P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE
Deposited 1997-08-11
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Not recorded
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1ASJ
P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE
Deposited 1997-08-11
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Not recorded
|
SPH SPHINGOSINE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1ASJ
P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE
Deposited 1997-08-11
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Not recorded
|
SPH SPHINGOSINE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1ASJ
P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE
Deposited 1997-08-11
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Not recorded
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1ASJ
P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE
Deposited 1997-08-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 150
PDB declaration: 150-meric
|
Chain 1
579–880(302 aa)
Fragment:VIRUS PROTOMER
Chain 2
69–340(272 aa)
Fragment:VIRUS PROTOMER
Chain 3
341–578(238 aa)
Fragment:VIRUS PROTOMER
|
Not recorded
|
SPH SPHINGOSINE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis;pH 7.5;VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å
|
|
1HXS
CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION
Deposited 2001-01-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-MERIC
|
Chain 1
579–880(302 aa)
Fragment:RESIDUES 579-880
Chain 2
69–340(272 aa)
Fragment:RESIDUES 69-340
Chain 3
341–577(237 aa)
Fragment:RESIDUES 341-577
Chain 4
1–68(68 aa)
Fragment:RESIDUES 1-68
|
Not recorded
|
PLM PALMITIC ACID × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7;277 K;10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å
|
|
1HXS
CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION
Deposited 2001-01-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
579–880(302 aa)
Fragment:RESIDUES 579-880
Chain 2
69–340(272 aa)
Fragment:RESIDUES 69-340
Chain 3
341–577(237 aa)
Fragment:RESIDUES 341-577
Chain 4
1–68(68 aa)
Fragment:RESIDUES 1-68
|
Not recorded
|
PLM PALMITIC ACID × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7;277 K;10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å
|
|
1HXS
CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION
Deposited 2001-01-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 20
PDB declaration: eicosameric
|
Chain 1
579–880(302 aa)
Fragment:RESIDUES 579-880
Chain 2
69–340(272 aa)
Fragment:RESIDUES 69-340
Chain 3
341–577(237 aa)
Fragment:RESIDUES 341-577
Chain 4
1–68(68 aa)
Fragment:RESIDUES 1-68
|
Not recorded
|
PLM PALMITIC ACID × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7;277 K;10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å
|
|
1HXS
CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION
Deposited 2001-01-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 24
PDB declaration: 24-meric
|
Chain 1
579–880(302 aa)
Fragment:RESIDUES 579-880
Chain 2
69–340(272 aa)
Fragment:RESIDUES 69-340
Chain 3
341–577(237 aa)
Fragment:RESIDUES 341-577
Chain 4
1–68(68 aa)
Fragment:RESIDUES 1-68
|
Not recorded
|
PLM PALMITIC ACID × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7;277 K;10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å
|
|
1HXS
CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION
Deposited 2001-01-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
579–880(302 aa)
Fragment:RESIDUES 579-880
Chain 2
69–340(272 aa)
Fragment:RESIDUES 69-340
Chain 3
341–577(237 aa)
Fragment:RESIDUES 341-577
Chain 4
1–68(68 aa)
Fragment:RESIDUES 1-68
|
Not recorded
|
PLM PALMITIC ACID × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7;277 K;10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å
|
|
1HXS
CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION
Deposited 2001-01-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein homooligomer
Homooligomer;Protein × 120
PDB declaration: 120-meric
|
Chain 1
579–880(302 aa)
Fragment:RESIDUES 579-880
Chain 2
69–340(272 aa)
Fragment:RESIDUES 69-340
Chain 3
341–577(237 aa)
Fragment:RESIDUES 341-577
Chain 4
1–68(68 aa)
Fragment:RESIDUES 1-68
|
Not recorded
|
PLM PALMITIC ACID × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7;277 K;10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å
|
|
1L1N
POLIOVIRUS 3C PROTEINASE
Deposited 2002-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1565–1747(183 aa)
Fragment:Residues 1565-1747
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;293 K;ammonium sulfate, glycerol, mercaptoethanol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.259
|
|
1L1N
POLIOVIRUS 3C PROTEINASE
Deposited 2002-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1565–1747(183 aa)
Fragment:Residues 1565-1747
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;293 K;ammonium sulfate, glycerol, mercaptoethanol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.259
|
|
1NG7
The Solution Structure of the Soluble Domain of Poliovirus 3A Protein
Deposited 2002-12-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1456–1514(59 aa)
Fragment:Poliovirus 3A-N
Chain B
1456–1514(59 aa)
Fragment:Poliovirus 3A-N
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;25 K;Ionic strength (raw mmCIF value) 20 mM potassium phosphate, 50 mM NaCl;Pressure ambient
NMR measurement conditions
pH 7;25 K;Ionic strength (raw mmCIF value) 10 mM tris, 50 mM NaCl;Pressure ambient
NMR sample composition
1-3 mM 3A-N U-95% 13C;U-99% 15N; 20mM phosphate buffer NA; 100% D2O | 100% D2O
NMR sample composition
1-3 mM 3A-N U-99% 15N; 20mM phosphate buffer NA; 95% H2O, 5% D2O | 95% H2O/5% D2O
NMR sample composition
1.5 mM 3A-N NA; 1.5 mM 3A-N U-95% 13C;U-99% 15N; 20mM phosphate buffer NA; 100% D2O | 100% D2O
NMR sample composition
2 mM 3A-N U-99% 15N; 10 mM tris buffer NA; 95% H2O, 5% D2O | 95% H2O/5% D2O
NMR sample composition
1-3 mM 3A-N U-95% 13C;U-99% 15N; 20mM phosphate buffer NA; 95% H2O, 5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|
|
1NN8
CryoEM structure of poliovirus receptor bound to poliovirus
Deposited 2003-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 420
PDB declaration: 420-MERIC
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–575(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 60
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 15.00 Å
|
|
1NN8
CryoEM structure of poliovirus receptor bound to poliovirus
Deposited 2003-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–575(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 1
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 15.00 Å
|
|
1NN8
CryoEM structure of poliovirus receptor bound to poliovirus
Deposited 2003-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 35
PDB declaration: 35-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–575(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 5
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 15.00 Å
|
|
1NN8
CryoEM structure of poliovirus receptor bound to poliovirus
Deposited 2003-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 42
PDB declaration: 42-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–575(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 6
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 15.00 Å
|
|
1NN8
CryoEM structure of poliovirus receptor bound to poliovirus
Deposited 2003-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–575(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 1
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 15.00 Å
|
|
1PO1
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO1
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO1
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO1
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO1
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO1
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 150
PDB declaration: 150-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO2
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO2
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO2
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO2
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO2
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1PO2
POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION
Deposited 1997-01-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 150
PDB declaration: 150-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.
|
Resolution 2.90 Å
|
|
1POV
ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION
Deposited 1995-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 180
PDB declaration: 180-MERIC
|
Chain 0
1–340(340 aa)
Chain 1
579–880(302 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 60
SPH SPHINGOSINE × 60
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
1POV
ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION
Deposited 1995-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain 0
1–340(340 aa)
Chain 1
579–880(302 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 1
SPH SPHINGOSINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
1POV
ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION
Deposited 1995-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 15
PDB declaration: pentadecameric
|
Chain 0
1–340(340 aa)
Chain 1
579–880(302 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 5
SPH SPHINGOSINE × 5
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
1POV
ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION
Deposited 1995-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 18
PDB declaration: octadecameric
|
Chain 0
1–340(340 aa)
Chain 1
579–880(302 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 6
SPH SPHINGOSINE × 6
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
1POV
ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION
Deposited 1995-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain 0
1–340(340 aa)
Chain 1
579–880(302 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 1
SPH SPHINGOSINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
1POV
ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION
Deposited 1995-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein homooligomer
Homooligomer;Protein × 90
PDB declaration: 90-meric
|
Chain 0
1–340(340 aa)
Chain 1
579–880(302 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 30
SPH SPHINGOSINE × 30
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
1RA6
Poliovirus Polymerase Full Length Apo Structure
Deposited 2003-10-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
Fragment:RNA-directed RNA polymerase (residue 1748-2208)
|
Mutation:L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.00 Å
R-free 0.247
|
|
1RA7
Poliovirus Polymerase with GTP
Deposited 2003-10-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
Fragment:RNA-directed RNA polymerase (residue 1748-2208)
|
Mutation:L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
ACY ACETIC ACID × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.35 Å
R-free 0.259
|
|
1RAJ
Poliovirus Polymerase with a 68 residue N-terminal truncation
Deposited 2003-10-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1816–2208(393 aa)
Fragment:RNA-directed RNA polymerase
|
Mutation:L446A, R455D
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium formate, sodium chloride, HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.50 Å
R-free 0.262
|
|
1RDR
POLIOVIRUS 3D POLYMERASE
Deposited 1998-04-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
|
Not recorded
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.6;pH 6.6
|
Resolution 2.40 Å
R-free 0.274
|
|
1TQL
POLIOVIRUS POLYMERASE G1A MUTANT
Deposited 2004-06-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
|
Mutation:G1A, L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium acetate, cacodylate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å
R-free 0.262
|
|
1VBD
POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206
Deposited 1996-01-02
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1VBD
POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206
Deposited 1996-01-02
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1VBD
POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206
Deposited 1996-01-02
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1VBD
POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206
Deposited 1996-01-02
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1VBD
POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206
Deposited 1996-01-02
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1VBD
POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206
Deposited 1996-01-02
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 150
PDB declaration: 150-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
|
Not recorded
|
J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1XYR
Poliovirus 135S cell entry intermediate
Deposited 2004-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 420
PDB declaration: 420-MERIC
|
Chain 1
649–880(232 aa)
Fragment:residues 649-880
Chain 2
96–332(237 aa)
Fragment:residues 96-332
Chain 3
390–571(182 aa)
Fragment:residues 390-571
Chain 5
341–352(12 aa)
Fragment:residues 341-352
Chain 6
354–389(36 aa)
Fragment:residues 354-389
Chain 7
81–94(14 aa)
Fragment:residues 81-94
Chain 8
620–630(11 aa)
Fragment:residues 620-630
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2;pH 7.4;20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE;Plunge freezing into liquid ethane
|
Resolution 11.00 Å
|
|
1XYR
Poliovirus 135S cell entry intermediate
Deposited 2004-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 7
PDB declaration: heptameric
|
Chain 1
649–880(232 aa)
Fragment:residues 649-880
Chain 2
96–332(237 aa)
Fragment:residues 96-332
Chain 3
390–571(182 aa)
Fragment:residues 390-571
Chain 5
341–352(12 aa)
Fragment:residues 341-352
Chain 6
354–389(36 aa)
Fragment:residues 354-389
Chain 7
81–94(14 aa)
Fragment:residues 81-94
Chain 8
620–630(11 aa)
Fragment:residues 620-630
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2;pH 7.4;20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE;Plunge freezing into liquid ethane
|
Resolution 11.00 Å
|
|
1XYR
Poliovirus 135S cell entry intermediate
Deposited 2004-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 35
PDB declaration: 35-meric
|
Chain 1
649–880(232 aa)
Fragment:residues 649-880
Chain 2
96–332(237 aa)
Fragment:residues 96-332
Chain 3
390–571(182 aa)
Fragment:residues 390-571
Chain 5
341–352(12 aa)
Fragment:residues 341-352
Chain 6
354–389(36 aa)
Fragment:residues 354-389
Chain 7
81–94(14 aa)
Fragment:residues 81-94
Chain 8
620–630(11 aa)
Fragment:residues 620-630
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2;pH 7.4;20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE;Plunge freezing into liquid ethane
|
Resolution 11.00 Å
|
|
1XYR
Poliovirus 135S cell entry intermediate
Deposited 2004-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 42
PDB declaration: 42-meric
|
Chain 1
649–880(232 aa)
Fragment:residues 649-880
Chain 2
96–332(237 aa)
Fragment:residues 96-332
Chain 3
390–571(182 aa)
Fragment:residues 390-571
Chain 5
341–352(12 aa)
Fragment:residues 341-352
Chain 6
354–389(36 aa)
Fragment:residues 354-389
Chain 7
81–94(14 aa)
Fragment:residues 81-94
Chain 8
620–630(11 aa)
Fragment:residues 620-630
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2;pH 7.4;20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE;Plunge freezing into liquid ethane
|
Resolution 11.00 Å
|
|
1XYR
Poliovirus 135S cell entry intermediate
Deposited 2004-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 7
PDB declaration: heptameric
|
Chain 1
649–880(232 aa)
Fragment:residues 649-880
Chain 2
96–332(237 aa)
Fragment:residues 96-332
Chain 3
390–571(182 aa)
Fragment:residues 390-571
Chain 5
341–352(12 aa)
Fragment:residues 341-352
Chain 6
354–389(36 aa)
Fragment:residues 354-389
Chain 7
81–94(14 aa)
Fragment:residues 81-94
Chain 8
620–630(11 aa)
Fragment:residues 620-630
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2;pH 7.4;20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE;Plunge freezing into liquid ethane
|
Resolution 11.00 Å
|
|
2BBP
NMR structures of the peptide linked to the genome (VPg) of poliovirus
Deposited 2005-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1544–1565(22 aa)
Fragment:residues 1-22
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;283 K;Ionic strength (raw mmCIF value) 10 mM;Pressure 1
NMR sample composition
3.7 mM peptide, 10 mM Na phosphate buffer, pH 7.2, DSS, 10% D20, 90% H2O | 10% D20, 90% H2O
|
Resolution not provided
|
|
2IJD
Crystal Structure of the Poliovirus Precursor Protein 3CD
Deposited 2006-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain 1
1565–2208(644 aa)
|
Mutation:E55A, D58A, E63A, C147A, L629D, R638D
|
ZN ZINC ION × 2
SO4 SULFATE ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;2 M ammonium sulfate, 0.1 M HEPES, 0.3% Jeffamine M600, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.40 Å
R-free 0.231
|
|
2IJD
Crystal Structure of the Poliovirus Precursor Protein 3CD
Deposited 2006-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain 2
1565–2208(644 aa)
|
Mutation:E55A, D58A, E63A, C147A, L629D, R638D
|
ZN ZINC ION × 2
SO4 SULFATE ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;2 M ammonium sulfate, 0.1 M HEPES, 0.3% Jeffamine M600, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.40 Å
R-free 0.231
|
|
2IJF
Crystal Structure of the Poliovirus RNA-Dependent RNA Polymerase Fidelity Mutant 3Dpol G64S
Deposited 2006-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
|
Mutation:G64S, L446D, R455D
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;2M sodium acetate, 0.1 M HEPES, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.00 Å
R-free 0.244
|
|
2ILY
Crystal structure of poliovirus polymerase complexed with ATP and Mg2+
Deposited 2006-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
Fragment:RNA-directed RNA polymerase, residues 461-1748
|
Mutation:L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NA SODIUM ION × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
ACY ACETIC ACID × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium acetate, cacodylate, dtt, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.60 Å
R-free 0.250
|
|
2ILZ
Crystal structure of poliovirus polymerase complexed with GTP and Mn2+
Deposited 2006-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
Fragment:RNA-directed RNA polymerase, residues 1748-2208
|
Mutation:L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MN MANGANESE (II) ION × 2
NA SODIUM ION × 2
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
ACY ACETIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium acetate, cacodylate, dtt, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.50 Å
R-free 0.255
|
|
2IM0
Crystal structure of poliovirus polymerase complexed with CTP and Mg2+
Deposited 2006-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
Fragment:RNA-directed RNA polymerase, residues 1748-2208
|
Mutation:L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NA SODIUM ION × 1
CTP CYTIDINE-5'-TRIPHOSPHATE × 1
ACY ACETIC ACID × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium acetate, cacodylate, dtt, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.25 Å
R-free 0.260
|
|
2IM1
Crystal structure of poliovirus polymerase complexed with CTP and Mn2+
Deposited 2006-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
Fragment:RNA-directed RNA polymerase, residues 1748-2208
|
Mutation:L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MN MANGANESE (II) ION × 3
NA SODIUM ION × 1
CTP CYTIDINE-5'-TRIPHOSPHATE × 1
ACY ACETIC ACID × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.50 Å
R-free 0.268
|
|
2IM2
Crystal structure of poliovirus polymerase complexed with UTP and Mg2+
Deposited 2006-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
Fragment:RNA-directed RNA polymerase, residues 1748-2208
|
Mutation:L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NA SODIUM ION × 1
UTP URIDINE 5'-TRIPHOSPHATE × 1
ACY ACETIC ACID × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.35 Å
R-free 0.267
|
|
2IM3
Crystal structure of poliovirus polymerase complexed with UTP and Mn2+
Deposited 2006-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1748–2208(461 aa)
Fragment:RNA-directed RNA polymerase, residues 1748-2208
|
Mutation:L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MN MANGANESE (II) ION × 2
NA SODIUM ION × 1
UTP URIDINE 5'-TRIPHOSPHATE × 1
ACY ACETIC ACID × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.60 Å
R-free 0.269
|
|
2PLV
STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS
Deposited 1989-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-MERIC
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 60
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.88 Å
|
|
2PLV
STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS
Deposited 1989-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.88 Å
|
|
2PLV
STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS
Deposited 1989-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 20
PDB declaration: eicosameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 5
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.88 Å
|
|
2PLV
STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS
Deposited 1989-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 24
PDB declaration: 24-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 6
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.88 Å
|
|
2PLV
STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS
Deposited 1989-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.88 Å
|
|
2PLV
STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS
Deposited 1989-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein homooligomer
Homooligomer;Protein × 120
PDB declaration: 120-meric
|
Chain 1
579–880(302 aa)
Chain 2
69–340(272 aa)
Chain 3
341–578(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 30
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.88 Å
|
|
3EPC
CryoEM structure of poliovirus receptor bound to poliovirus type 1
Deposited 2008-09-29
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
599–881(283 aa)
Chain 2
74–341(268 aa)
Chain 3
342–576(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 60
MYR MYRISTIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å
|
|
3EPC
CryoEM structure of poliovirus receptor bound to poliovirus type 1
Deposited 2008-09-29
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
599–881(283 aa)
Chain 2
74–341(268 aa)
Chain 3
342–576(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å
|
|
3EPC
CryoEM structure of poliovirus receptor bound to poliovirus type 1
Deposited 2008-09-29
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
599–881(283 aa)
Chain 2
74–341(268 aa)
Chain 3
342–576(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 5
MYR MYRISTIC ACID × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å
|
|
3EPC
CryoEM structure of poliovirus receptor bound to poliovirus type 1
Deposited 2008-09-29
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
599–881(283 aa)
Chain 2
74–341(268 aa)
Chain 3
342–576(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 6
MYR MYRISTIC ACID × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å
|
|
3EPC
CryoEM structure of poliovirus receptor bound to poliovirus type 1
Deposited 2008-09-29
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
599–881(283 aa)
Chain 2
74–341(268 aa)
Chain 3
342–576(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å
|
|
3IYB
Poliovirus early RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-meric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3IYB
Poliovirus early RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3IYB
Poliovirus early RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3IYB
Poliovirus early RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3IYB
Poliovirus early RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3IYC
Poliovirus late RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-meric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3IYC
Poliovirus late RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3IYC
Poliovirus late RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3IYC
Poliovirus late RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3IYC
Poliovirus late RNA-release intermediate
Deposited 2009-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
647–881(235 aa)
Chain 4
97–341(245 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å
|
|
3J3O
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 420
PDB declaration: 420-MERIC
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Not recorded
|
SPH SPHINGOSINE × 60
MYR MYRISTIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å
|
|
3J3O
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Not recorded
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å
|
|
3J3O
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 35
PDB declaration: 35-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Not recorded
|
SPH SPHINGOSINE × 5
MYR MYRISTIC ACID × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å
|
|
3J3O
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 42
PDB declaration: 42-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Not recorded
|
SPH SPHINGOSINE × 6
MYR MYRISTIC ACID × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å
|
|
3J3O
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Not recorded
|
SPH SPHINGOSINE × 1
MYR MYRISTIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å
|
|
3J3P
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å
|
|
3J3P
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å
|
|
3J3P
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å
|
|
3J3P
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å
|
|
3J3P
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex
Deposited 2013-04-10
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2;pH 7.5;20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging;Cryogen ETHANE;Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å
|
|
3J48
Cryo-EM structure of Poliovirus 135S particles
Deposited 2013-06-28
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 180
PDB declaration: 180-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2;pH 7.4;20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane;90 K;Cryogen ETHANE;Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å
|
|
3J48
Cryo-EM structure of Poliovirus 135S particles
Deposited 2013-06-28
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2;pH 7.4;20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane;90 K;Cryogen ETHANE;Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å
|
|
3J48
Cryo-EM structure of Poliovirus 135S particles
Deposited 2013-06-28
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 15
PDB declaration: pentadecameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2;pH 7.4;20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane;90 K;Cryogen ETHANE;Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å
|
|
3J48
Cryo-EM structure of Poliovirus 135S particles
Deposited 2013-06-28
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 18
PDB declaration: octadecameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2;pH 7.4;20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane;90 K;Cryogen ETHANE;Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å
|
|
3J48
Cryo-EM structure of Poliovirus 135S particles
Deposited 2013-06-28
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2;pH 7.4;20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane;90 K;Cryogen ETHANE;Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å
|
|
3J8F
Cryo-EM reconstruction of poliovirus-receptor complex
Deposited 2014-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 300
PDB declaration: 300-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7;PBS
cryo-EM vitrification conditions
Sample mixed and frozen within 2 minutes.;120 K;Cryogen ETHANE;Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
|
Resolution 3.70 Å
|
|
3J8F
Cryo-EM reconstruction of poliovirus-receptor complex
Deposited 2014-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7;PBS
cryo-EM vitrification conditions
Sample mixed and frozen within 2 minutes.;120 K;Cryogen ETHANE;Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
|
Resolution 3.70 Å
|
|
3J8F
Cryo-EM reconstruction of poliovirus-receptor complex
Deposited 2014-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7;PBS
cryo-EM vitrification conditions
Sample mixed and frozen within 2 minutes.;120 K;Cryogen ETHANE;Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
|
Resolution 3.70 Å
|
|
3J8F
Cryo-EM reconstruction of poliovirus-receptor complex
Deposited 2014-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Other combination
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7;PBS
cryo-EM vitrification conditions
Sample mixed and frozen within 2 minutes.;120 K;Cryogen ETHANE;Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
|
Resolution 3.70 Å
|
|
3J8F
Cryo-EM reconstruction of poliovirus-receptor complex
Deposited 2014-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7;PBS
cryo-EM vitrification conditions
Sample mixed and frozen within 2 minutes.;120 K;Cryogen ETHANE;Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
|
Resolution 3.70 Å
|
|
3J9F
Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C
Deposited 2015-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 420
PDB declaration: 420-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 60
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 60
|
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å
|
|
3J9F
Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C
Deposited 2015-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å
|
|
3J9F
Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C
Deposited 2015-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 35
PDB declaration: 35-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 5
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
|
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å
|
|
3J9F
Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C
Deposited 2015-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Other combination
Heteromer;Protein × 42
PDB declaration: 42-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 6
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å
|
|
3J9F
Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C
Deposited 2015-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å
|
|
3JBC
Complex of Poliovirus with VHH PVSP29F
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K;Cryogen ETHANE;Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å
|
|
3JBC
Complex of Poliovirus with VHH PVSP29F
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K;Cryogen ETHANE;Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å
|
|
3JBC
Complex of Poliovirus with VHH PVSP29F
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K;Cryogen ETHANE;Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å
|
|
3JBC
Complex of Poliovirus with VHH PVSP29F
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K;Cryogen ETHANE;Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å
|
|
3JBC
Complex of Poliovirus with VHH PVSP29F
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K;Cryogen ETHANE;Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å
|
|
3JBD
Complex of poliovirus with VHH PVSP6A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-MERIC
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot;154 K;Cryogen ETHANE;Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å
|
|
3JBD
Complex of poliovirus with VHH PVSP6A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot;154 K;Cryogen ETHANE;Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å
|
|
3JBD
Complex of poliovirus with VHH PVSP6A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot;154 K;Cryogen ETHANE;Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å
|
|
3JBD
Complex of poliovirus with VHH PVSP6A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot;154 K;Cryogen ETHANE;Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å
|
|
3JBD
Complex of poliovirus with VHH PVSP6A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
PBS;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot;154 K;Cryogen ETHANE;Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å
|
|
3JBE
Complex of poliovirus with VHH PVSS8A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å
|
|
3JBE
Complex of poliovirus with VHH PVSS8A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å
|
|
3JBE
Complex of poliovirus with VHH PVSS8A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å
|
|
3JBE
Complex of poliovirus with VHH PVSS8A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å
|
|
3JBE
Complex of poliovirus with VHH PVSS8A
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å
|
|
3JBF
Complex of poliovirus with VHH PVSP19B
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å
|
|
3JBF
Complex of poliovirus with VHH PVSP19B
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å
|
|
3JBF
Complex of poliovirus with VHH PVSP19B
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å
|
|
3JBF
Complex of poliovirus with VHH PVSP19B
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å
|
|
3JBF
Complex of poliovirus with VHH PVSP19B
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å
|
|
3JBG
Complex of poliovirus with VHH PVSS21E
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å
|
|
3JBG
Complex of poliovirus with VHH PVSS21E
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å
|
|
3JBG
Complex of poliovirus with VHH PVSS21E
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å
|
|
3JBG
Complex of poliovirus with VHH PVSS21E
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å
|
|
3JBG
Complex of poliovirus with VHH PVSS21E
Deposited 2015-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–578(237 aa)
Fragment:UNP residues 342-578
Chain 4
2–69(68 aa)
Fragment:UNP residues 2-69
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PLM PALMITIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O;pH 7.4;145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot;154 K;Cryogen ETHANE;Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å
|
|
4DCD
1.6A resolution structure of PolioVirus 3C Protease Containing a covalently bound dipeptidyl inhibitor
Deposited 2012-01-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1566–1748(183 aa)
Fragment:unp residues 1566-1748
|
Not recorded
|
DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1
K36 (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid × 1
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;298 K;30% (w/v) PEG 5000 MME, 100 mM MES, 200 mM ammonium sulfate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.69 Å
R-free 0.189
|
|
4K4S
Poliovirus polymerase elongation complex (r3_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain A
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D
|
ZN ZINC ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;sitting drop, temperature 289K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 2.40 Å
R-free 0.245
|
|
4K4S
Poliovirus polymerase elongation complex (r3_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain E
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D
|
ZN ZINC ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;sitting drop, temperature 289K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 2.40 Å
R-free 0.245
|
|
4K4T
Poliovirus polymerase elongation complex (r4_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain A
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D
|
GOL GLYCEROL × 2
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.16 M MgCl2, 0.08 M Tris-HCl, 24% (w/v) PEG 4000, 20% (v/v) glycerol and directly frozen for data collection , VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.75 Å
R-free 0.262
|
|
4K4T
Poliovirus polymerase elongation complex (r4_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain E
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D
|
GOL GLYCEROL × 2
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.16 M MgCl2, 0.08 M Tris-HCl, 24% (w/v) PEG 4000, 20% (v/v) glycerol and directly frozen for data collection , VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.75 Å
R-free 0.262
|
|
4K4U
Poliovirus polymerase elongation complex (r5_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain A
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D, C290M
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), pH 8.5-9.0, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.85 Å
R-free 0.276
|
|
4K4U
Poliovirus polymerase elongation complex (r5_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain E
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D, C290M
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), pH 8.5-9.0, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.85 Å
R-free 0.276
|
|
4K4V
Poliovirus polymerase elongation complex (r5+1_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D, C290M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27% (v/v) xylitol with dCTP prior to freezing, pH pH 8.5-9.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.63 Å
R-free 0.273
|
|
4K4V
Poliovirus polymerase elongation complex (r5+1_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain E
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D, C290M
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27% (v/v) xylitol with dCTP prior to freezing, pH pH 8.5-9.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.63 Å
R-free 0.273
|
|
4K4W
Poliovirus polymerase elongation complex (r5+2_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D, C290A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol with CTP prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.69 Å
R-free 0.256
|
|
4K4W
Poliovirus polymerase elongation complex (r5+2_form)
Deposited 2013-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain E
1749–2209(461 aa)
Fragment:unp residues 1749-2209
|
Mutation:L446D, C290A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol with CTP prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.69 Å
R-free 0.256
|
|
4NLO
Poliovirus Polymerase - C290I Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:C290I, L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 5
1PE PENTAETHYLENE GLYCOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.20 Å
R-free 0.251
|
|
4NLP
Poliovirus Polymerase - C290V Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:C290V, L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 5
1PE PENTAETHYLENE GLYCOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid, and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.20 Å
R-free 0.248
|
|
4NLQ
Poliovirus Polymerase - C290F Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:C290F, L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 7
1PE PENTAETHYLENE GLYCOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å
R-free 0.245
|
|
4NLR
Poliovirus Polymerase - C290S Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:C290S, L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 6
1PE PENTAETHYLENE GLYCOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.00 Å
R-free 0.240
|
|
4NLS
Poliovirus Polymerase - S288A Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:S288A (+L446D,R455D in Thumb)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 5
1PE PENTAETHYLENE GLYCOL × 3
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.00 Å
R-free 0.256
|
|
4NLT
Poliovirus Polymerase - S291P Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:S291P , L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 5
1PE PENTAETHYLENE GLYCOL × 4
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
Hanging drop;pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid (pH 7.0) and 2 mM DTT, Hanging drop, temperature 289K
|
Resolution 2.50 Å
R-free 0.256
|
|
4NLU
Poliovirus Polymerase - G289A Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:G289A, L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 6
1PE PENTAETHYLENE GLYCOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid, and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.10 Å
R-free 0.246
|
|
4NLV
Poliovirus Polymerase - G289A/C290F Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:G289A,C290F, L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 8
1PE PENTAETHYLENE GLYCOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid, 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å
R-free 0.240
|
|
4NLW
Poliovirus Polymerase - G289A/C290I Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:G289A, C290I, L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 5
1PE PENTAETHYLENE GLYCOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.10 Å
R-free 0.242
|
|
4NLX
Poliovirus Polymerase - G289A/C290V Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:G289A, C290V, L446D, 455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 5
1PE PENTAETHYLENE GLYCOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.60 Å
R-free 0.236
|
|
4NLY
Poliovirus Polymerase - C290E Loop Mutant
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:C290E, L446D, R455D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACY ACETIC ACID × 5
1PE PENTAETHYLENE GLYCOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;289 K;Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å
R-free 0.239
|
|
4R0E
Crystal Structure of the Poliovirus RNA-Dependent RNA Polymerase Low-Fidelity Mutant 3Dpol H273R
Deposited 2014-07-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1749–2209(461 aa)
|
Mutation:H273R, L446D, R455D
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;293 K;Mixed equal volumes of protein 10mg/ml in buffer (5mM Tris pH 7.5, 200mM NaCl, 0.1mM EDTA, 2mM DTT) and reservoir solution (2M Na Acetate, 0.1 M Na Cacodylate pH 6.8) prior to vapor diffusion, VAPOR DIFFUSION, temperature 293K
|
Resolution 3.00 Å
R-free 0.218
|
|
5KTZ
expanded poliovirus in complex with VHH 12B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 240
PDB declaration: 240-meric
|
Chain 1
636–858(223 aa)
Fragment:UNP residues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-572
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å
|
|
5KTZ
expanded poliovirus in complex with VHH 12B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
636–858(223 aa)
Fragment:UNP residues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-572
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å
|
|
5KTZ
expanded poliovirus in complex with VHH 12B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain 1
636–858(223 aa)
Fragment:UNP residues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-572
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å
|
|
5KTZ
expanded poliovirus in complex with VHH 12B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 24
PDB declaration: 24-meric
|
Chain 1
636–858(223 aa)
Fragment:UNP residues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-572
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å
|
|
5KTZ
expanded poliovirus in complex with VHH 12B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
636–858(223 aa)
Fragment:UNP residues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-572
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å
|
|
5KU0
expanded poliovirus in complex with VHH 17B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 240
PDB declaration: 240-meric
|
Chain 1
636–858(223 aa)
Fragment:UNP reisdues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KU0
expanded poliovirus in complex with VHH 17B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
636–858(223 aa)
Fragment:UNP reisdues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KU0
expanded poliovirus in complex with VHH 17B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain 1
636–858(223 aa)
Fragment:UNP reisdues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KU0
expanded poliovirus in complex with VHH 17B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 24
PDB declaration: 24-meric
|
Chain 1
636–858(223 aa)
Fragment:UNP reisdues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KU0
expanded poliovirus in complex with VHH 17B
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
636–858(223 aa)
Fragment:UNP reisdues 636-858
Chain 2
70–338(269 aa)
Fragment:UNP residues 70-338
Chain 3
342–572(231 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KU2
expanded poliovirus in complex with VHH 7A
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 240
PDB declaration: 240-meric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KU2
expanded poliovirus in complex with VHH 7A
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KU2
expanded poliovirus in complex with VHH 7A
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KU2
expanded poliovirus in complex with VHH 7A
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 24
PDB declaration: 24-meric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KU2
expanded poliovirus in complex with VHH 7A
Deposited 2016-07-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å
|
|
5KWL
expanded poliovirus in complex with VHH 10E
Deposited 2016-07-18
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 240
PDB declaration: 240-meric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å
|
|
5KWL
expanded poliovirus in complex with VHH 10E
Deposited 2016-07-18
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å
|
|
5KWL
expanded poliovirus in complex with VHH 10E
Deposited 2016-07-18
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å
|
|
5KWL
expanded poliovirus in complex with VHH 10E
Deposited 2016-07-18
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 24
PDB declaration: 24-meric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å
|
|
5KWL
expanded poliovirus in complex with VHH 10E
Deposited 2016-07-18
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
650–858(209 aa)
Fragment:UNP residues 650-858
Chain 2
70–337(268 aa)
Fragment:UNP residues 70-337
Chain 3
342–571(230 aa)
Fragment:UNP residues 342-571
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å
|
|
5Z3Q
Crystal Structure of a Soluble Fragment of Poliovirus 2C ATPase (2.55 Angstrom)
Deposited 2018-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1243–1456(214 aa)
Fragment:UNP residues 1243-1456
Chain C
1243–1456(214 aa)
Fragment:UNP residues 1243-1456
Chain D
1243–1456(214 aa)
Fragment:UNP residues 1243-1456
Chain E
1243–1456(214 aa)
Fragment:UNP residues 1243-1456
|
Mutation:E207A, K209A,R149A
Mutation:E207A, K209A,R149A
Mutation:E207A, K209A,R149A
Mutation:E207A, K209A,R149A
|
ZN ZINC ION × 4
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;MgCl2 0.2M, MES 0.1M pH 6.5, 3%(v/v) PGE4000, Polypropylene glycol P 400 (9.2% v/v) , 0.5mM TECP HCl
|
Resolution 2.54 Å
R-free 0.265
|
|
5Z3Q
Crystal Structure of a Soluble Fragment of Poliovirus 2C ATPase (2.55 Angstrom)
Deposited 2018-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1243–1456(214 aa)
Fragment:UNP residues 1243-1456
|
Mutation:E207A, K209A,R149A
|
ZN ZINC ION × 1
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;MgCl2 0.2M, MES 0.1M pH 6.5, 3%(v/v) PGE4000, Polypropylene glycol P 400 (9.2% v/v) , 0.5mM TECP HCl
|
Resolution 2.54 Å
R-free 0.265
|
|
5Z3Q
Crystal Structure of a Soluble Fragment of Poliovirus 2C ATPase (2.55 Angstrom)
Deposited 2018-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain H
1243–1456(214 aa)
Fragment:UNP residues 1243-1456
|
Mutation:E207A, K209A,R149A
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;MgCl2 0.2M, MES 0.1M pH 6.5, 3%(v/v) PGE4000, Polypropylene glycol P 400 (9.2% v/v) , 0.5mM TECP HCl
|
Resolution 2.54 Å
R-free 0.265
|
|
6HLV
Crystal structure of human ACBD3 GOLD domain in complex with 3A protein of poliovirus-1 (L24A mutant)
Deposited 2018-09-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1457–1514(58 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;12,5% w/v PEG 4000, 20% v/v 1,2,6-hexanetriol, 4% v/v tert-butanol, 1 mM rubidium chloride, 1 mM strontium chloride, 1 mM cesium acetate, 1 mM barium acetate, 100 mM GlyGly/AMPD pH 8.5
|
Resolution 2.50 Å
R-free 0.241
|
|
6P9O
Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 180
PDB declaration: 180-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
6P9O
Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
6P9O
Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 15
PDB declaration: pentadecameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
6P9O
Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 18
PDB declaration: octadecameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
6P9O
Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
6P9W
Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 180
PDB declaration: 180-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6P9W
Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6P9W
Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 15
PDB declaration: pentadecameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6P9W
Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 18
PDB declaration: octadecameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6P9W
Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map
Deposited 2019-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6PSZ
Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle
Deposited 2019-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 180
PDB declaration: 180-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6PSZ
Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle
Deposited 2019-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6PSZ
Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle
Deposited 2019-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 15
PDB declaration: pentadecameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6PSZ
Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle
Deposited 2019-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 18
PDB declaration: octadecameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6PSZ
Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle
Deposited 2019-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6Q0B
Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr
Deposited 2019-08-01
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 300
PDB declaration: 300-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–70(69 aa)
Fragment:UNP residues 2-70
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
6Q0B
Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr
Deposited 2019-08-01
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–70(69 aa)
Fragment:UNP residues 2-70
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
6Q0B
Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr
Deposited 2019-08-01
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 25
PDB declaration: 25-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–70(69 aa)
Fragment:UNP residues 2-70
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
6Q0B
Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr
Deposited 2019-08-01
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–70(69 aa)
Fragment:UNP residues 2-70
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
6Q0B
Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr
Deposited 2019-08-01
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain 1
580–881(302 aa)
Fragment:UNP residues 580-881
Chain 2
70–341(272 aa)
Fragment:UNP residues 70-341
Chain 3
342–579(238 aa)
Fragment:UNP residues 342-579
Chain 4
2–70(69 aa)
Fragment:UNP residues 2-70
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
8E8L
9H2 Fab-poliovirus 1 complex
Deposited 2022-08-25
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 360
PDB declaration: 360-meric
|
Chain 1
600–881(282 aa)
Chain 2
77–341(265 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å
|
|
8E8L
9H2 Fab-poliovirus 1 complex
Deposited 2022-08-25
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain 1
600–881(282 aa)
Chain 2
77–341(265 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å
|
|
8E8L
9H2 Fab-poliovirus 1 complex
Deposited 2022-08-25
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain 1
600–881(282 aa)
Chain 2
77–341(265 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å
|
|
8E8L
9H2 Fab-poliovirus 1 complex
Deposited 2022-08-25
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 36
PDB declaration: 36-meric
|
Chain 1
600–881(282 aa)
Chain 2
77–341(265 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å
|
|
8E8L
9H2 Fab-poliovirus 1 complex
Deposited 2022-08-25
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain 1
600–881(282 aa)
Chain 2
77–341(265 aa)
Chain 4
2–69(68 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å
|
|
9EYY
Poliovirus type 1 (strain Mahoney) native conformation stabilised virus-like particle (PV1 SC6b) from a yeast expression system.
Deposited 2024-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 180
PDB declaration: 180-meric
|
Chain A
580–881(302 aa)
Chain B
2–341(340 aa)
Chain C
342–579(238 aa)
|
Mutation:VP1 H248P
Mutation:VP2 T94A, VP2 D126E, VP4 R18G
Mutation:VP3 L119M, VP3 Q178L
|
PLM PALMITIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7;1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE;3-4 ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 3.30 Å
|
|
9EZ0
Poliovirus type 1 (strain Mahoney) expanded conformation stabilised virus-like particle (PV1 SC6b) from a yeast expression system.
Deposited 2024-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 180
PDB declaration: 180-meric
|
Chain A
580–881(302 aa)
Chain B
2–341(340 aa)
Chain C
342–579(238 aa)
|
Mutation:VP1 H248P
Mutation:VP2 T94A, VP2 D126E, VP4 R18G
Mutation:VP3 L119M, VP3 Q178L
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7;1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE;3-4 ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 3.30 Å
|
|
9F0K
Poliovirus type 1 (strain Mahoney) expanded conformation stabilised virus-like particle (PV1 SC6b) from a mammalian expression system
Deposited 2024-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 180
PDB declaration: 180-meric
|
Chain A
580–881(302 aa)
Chain B
2–341(340 aa)
Chain C
342–579(238 aa)
|
Mutation:VP1 H248P
Mutation:VP2 T25A, VP2 D57E, VP4 R18G
Mutation:VP3 L119M, VP3 Q178L
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7;1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE;3-4 ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 3.00 Å
|
|
9F3Q
Poliovirus type 1 (strain Mahoney) stabilised virus-like particle (PV1 SC6b) in complex with GPP3 and GSH.
Deposited 2024-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 180
PDB declaration: 180-meric
|
Chain A
580–881(302 aa)
Chain B
2–341(340 aa)
Chain C
342–579(238 aa)
|
Mutation:VP1 H248P
Mutation:VP2 T25A, VP2 D57E, VP4 R18G
Mutation:VP3 L119M, VP3 Q178L
|
YM2 1-[(3S)-5-[4-[(E)-ETHOXYIMINOMETHYL]PHENOXY]-3-METHYL-PENTYL]-3-PYRIDIN-4-YL-IMIDAZOLIDIN-2-ONE × 60
GSH Glutathione × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7;1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE;3-4 ul of sample blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 2.75 Å
|
|
9FQ2
Poliovirus 3C protease in H32 spacegroup
Deposited 2024-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1566–1748(183 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Shotgun ECO screen, well B9
1.6M Sodium citrate tribasic dihydrate
|
Resolution 2.37 Å
R-free 0.258
|
|
9FQ2
Poliovirus 3C protease in H32 spacegroup
Deposited 2024-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1566–1748(183 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Shotgun ECO screen, well B9
1.6M Sodium citrate tribasic dihydrate
|
Resolution 2.37 Å
R-free 0.258
|
|
9WAG
Yeast-expressed polio type 1 expanded virus-like particles
Deposited 2025-08-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 183
PDB declaration: 183-meric
|
Chain A
580–881(302 aa)
Chain B
70–341(272 aa)
Chain C
342–579(238 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.95 Å
|
|
9WAH
Yeast-expressed polio type 1 stabilized virus-like particles
Deposited 2025-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain F
1–69(69 aa)
Chain H
70–341(272 aa)
Chain I
342–579(238 aa)
Chain J
580–881(302 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.43 Å
|
|
9WAI
Yeast-expressed polio type 1 stablized virus-like particles with 3G10 Fab
Deposited 2025-08-12
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 714
PDB declaration: 1068-meric
|
Chain B
70–341(272 aa)
Chain C
342–579(238 aa)
Chain D
580–881(302 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.60 Å
|